Journal Name: Drug Resistance Updates
Journal Type:
ISSN: 13687646, 15322084
Country: United Kingdom
Subject Area and Category: Biochemistry, Genetics and Molecular Biology Cancer Research Medicine Infectious Diseases Oncology Pharmacology (medical) Pharmacology, Toxicology and Pharmaceutics Pharmacology
Publisher: Churchill Livingstone
Research Ranking: 2153
Publication Type: Journals
H-Index: 139
Coverage: 1998-2025
Editors-in-Chief: Dr. Zhe-Sheng (Jason) Chen, MD, PhD
Research Impact Score: 2.1
Impact Factor: 15.8
SCIMAGO SJR: 5.282
APC Cost: USD 5,410 (excluding taxes).
Submission Link: https://www.journals.elsevier.com/drug-resistance-updates
Contact Email: support@elsevier.com
Address: JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF
Overview
Sure! Here's a 500-word SEO-friendly article overview for "Drug Resistance Updates", which could work well for a blog, journal site, or health-related content platform:
Understanding Drug Resistance: Insights from Drug Resistance Updates
Overview
Drug resistance is one of the most pressing global health threats of the 21st century. As pathogens evolve and adapt, many standard treatments lose their effectiveness, leading to longer illnesses, increased medical costs, and higher mortality rates. Drug Resistance Updates is a peer-reviewed scientific journal that plays a crucial role in advancing our understanding of this critical issue. Focused on the molecular mechanisms, clinical implications, and epidemiological trends of antimicrobial resistance (AMR), this journal provides comprehensive insights for researchers, clinicians, and policymakers alike.
What is Drug Resistance?
Drug resistance occurs when microorganisms such as bacteria, viruses, fungi, or parasites evolve to withstand the drugs designed to kill them. This phenomenon can result from various factors, including genetic mutations, overuse or misuse of medications, and poor infection control practices. Antibiotic resistance is the most well-known form of drug resistance, but resistance can also occur with antiviral, antifungal, and antiparasitic agents.
Purpose of the Journal
Drug Resistance Updates serves as a critical resource for the scientific and medical communities. The journal publishes cutting-edge reviews and research updates that focus on:
- Mechanisms of resistance at the molecular and genetic levels
- Emerging resistance trends across various regions and settings
- New therapeutic strategies and drug development pipelines
- Policy and stewardship initiatives to combat resistance
- Global health implications and future research directions
By highlighting multidisciplinary perspectives, the journal fosters collaboration across microbiology, pharmacology, clinical medicine, and public health.
Why It Matters
Antimicrobial resistance is a growing concern that threatens to undermine decades of medical progress. Infections that were once easily treatable with antibiotics are now becoming more difficult and expensive to manage. This poses a significant threat not only to individual patients but to global public health systems.
Drug Resistance Updates provides the scientific foundation needed to drive innovation in diagnostics, treatment, and prevention. With expertly curated content and peer-reviewed reviews, the journal ensures that readers are kept up-to-date with the latest developments in drug resistance research.
Target Audience
The journal caters to a broad spectrum of professionals, including:
- Infectious disease specialists
- Microbiologists and geneticists
- Pharmacologists and medicinal chemists
- Public health officials and policy makers
- Academic researchers and educators
SEO Keywords:
- Drug resistance
- Antimicrobial resistance (AMR)
- Antibiotic resistance
- Drug Resistance Updates journal
- Emerging infectious diseases
- Resistance mechanisms
- Antimicrobial stewardship
- Public health and drug resistance
About
Drug Resistance Updates: A Leading Journal in Combating Drug Resistance
Drug Resistance Updates is a premier, peer-reviewed journal published bimonthly by Elsevier. It serves as a critical resource for researchers, clinicians, and healthcare professionals dedicated to understanding and overcoming drug resistance in infectious diseases and cancer. The journal offers comprehensive reviews, original research, and expert commentaries that bridge basic science and clinical practice.
Scope and Focus
The journal covers a broad spectrum of topics related to drug resistance, including:
- Molecular biology and biochemistry
- Cell biology and pharmacology
- Microbiology and oncology
- Preclinical therapeutics and clinical medicine
By integrating these disciplines, Drug Resistance Updates provides insights into the mechanisms of resistance and explores innovative strategies to counteract them citeturn0search0.
Editorial Excellence
Under the leadership of Editor-in-Chief Dr. Zhe-Sheng Chen from St. John's University, New York, the journal maintains rigorous peer-review standards. Articles are typically invited and authored by leading experts in the field, ensuring high-quality and authoritative content citeturn0search0.
Impact and Recognition
Drug Resistance Updates boasts impressive metrics that reflect its influence in the scientific community:
- Impact Factor: 15.8 (2023)
- CiteScore: 26.2
- h-index: 132
- SCImago Journal Rank (SJR): 4.665
The journal ranks in the top quartile (Q1) across multiple categories, including Pharmacology, Oncology, Infectious Diseases, and Cancer Research citeturn0search6turn0search4.
Timely and Efficient Publication
Committed to rapid dissemination of research, the journal offers:
- Time to First Decision: Approximately 3 days
- Review Time: Around 51 days
- Submission to Acceptance: Approximately 90 days
These timelines facilitate the swift sharing of critical findings with the global scientific community citeturn0search0.
Open Access and Accessibility
While Drug Resistance Updates primarily operates on a subscription model, it supports open access publishing. Authors can opt for open access with an article processing charge of $5,410, enhancing the visibility and reach of their work citeturn0search0.
Recent Highlights
The journal consistently features groundbreaking research, such as:
- Studies on fasting-mimicking diets enhancing the efficacy of CDK4/6 inhibitors in breast cancer
- Investigations into autophagy's role in immunotherapy resistance in KRAS-mutated pancreatic cancer
- Development of zebrafish patient-derived xenograft models to predict carboplatin resistance in ovarian cancer
These articles exemplify the journal's commitment to addressing pressing challenges in drug resistance citeturn0search0.
Scope
Sure! Here's a 500-word, SEO-friendly piece of content on the scope of drug resistance updates:
Scope of Drug Resistance Updates: A Vital Resource for the Global Health Community
Drug resistance has emerged as one of the most pressing public health threats of the 21st century. As bacteria, viruses, parasites, and fungi continue to evolve mechanisms to evade the effects of therapeutic agents, healthcare systems worldwide face growing challenges in treating once-manageable diseases. The journal Drug Resistance Updates plays a critical role in the fight against antimicrobial resistance (AMR), providing comprehensive and cutting-edge insights into the mechanisms, epidemiology, and strategies for combating drug-resistant pathogens.
What Is Drug Resistance Updates?
Drug Resistance Updates is a peer-reviewed scientific journal that serves as an authoritative resource for researchers, clinicians, and public health professionals. Its primary mission is to publish high-impact review articles and research updates that explore the rapidly evolving landscape of drug resistance. Topics covered include molecular mechanisms of resistance, clinical implications, surveillance data, novel therapeutic strategies, and public health policies.
Scope and Coverage
The scope of Drug Resistance Updates spans a broad range of disciplines within microbiology, pharmacology, and clinical medicine. Key areas of focus include:
- Antibiotic Resistance: In-depth reviews on resistance mechanisms in gram-positive and gram-negative bacteria, including MRSA, CRE, and drug-resistant Mycobacterium tuberculosis.
- Antiviral Resistance: Coverage of resistance patterns in HIV, hepatitis viruses, influenza, and emerging viral threats such as SARS-CoV-2.
- Antifungal Resistance: Updates on resistance in Candida, Aspergillus, and other clinically significant fungi.
- Antiparasitic Resistance: Focus on malaria, leishmaniasis, and other parasitic infections where resistance is impacting treatment efficacy.
- New Drug Development: Reviews of novel antibiotics, antivirals, and antifungals, including drug repurposing and next-generation therapies.
- Mechanistic Studies: Insights into genetic, biochemical, and cellular pathways leading to resistance.
- Epidemiology and Surveillance: Global trends and data on resistance outbreaks and regional patterns.
- Public Health and Policy: Discussions on antimicrobial stewardship, infection control, and strategies to slow resistance development.
Why It Matters
As resistance grows, treatment options narrow, leading to longer hospital stays, higher medical costs, and increased mortality. Staying updated on the latest research and developments is crucial for healthcare professionals and policy-makers. Drug Resistance Updates offers a centralized, credible source of information that facilitates evidence-based decision-making and fosters global collaboration.
SEO Keywords to Note
To enhance online visibility and relevance, this content integrates key SEO terms, including:
- Drug resistance
- Antimicrobial resistance (AMR)
- Antibiotic resistance updates
- Drug Resistance Updates journal
- Mechanisms of resistance
- Emerging infectious diseases
- Novel antimicrobial therapies
Final Thoughts
With the growing burden of drug resistance worldwide, Drug Resistance Updates stands out as a premier resource offering timely, scientifically rigorous content. Its broad scope and multidisciplinary approach make it indispensable for anyone involved in the fight against infectious diseases. Regular engagement with this journal helps the scientific and medical community stay one step ahead in the ongoing battle against resistant pathogens.